Sidley Austin LLP’s Geneva-based life sciences team leverages wide-ranging expertise across issues relating to all stages of the product lifecycle and caters to clients within the pharmaceutical, biotechnology, medical devices, novel foods and cosmetics industries. With prior experience at Swissmedic, Eva von Mühlenen heads up the practice and has extensive experience in both advisory and contentious regulatory matters. Tatjana Sachse advises on market access issues and international regulatory matters.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Billing & efficiency
Testimonials
Collated independently by Legal 500 research team.
- ‘Deep knowledge of the regulatory framework and also the business side of things.’
- ‘The regulatory background really comes through. In a space where your own opinion, however well informed, needs to take into account how regulators will react, understanding the drivers within the regulatory agency is critical.’
- ‘Excellent knowledge base, professionalism, responsiveness.’
- ‘Highly qualified, genuinely interested in the project, accommodating of needs and changes in these needs as the project evolved.’
- ‘Eva von Mühlenen has deep experience in the field from different angles, a deep understanding of what truly matters and the creativity to find adequate solutions.’
- ‘Eva von Mühlenen is an excellent healthcare and life science expert, with vast practical experience and practical insights into Swissmedic regulatory processes.’
Key clients
- Swiss Federal Institute of Technology Zürich
Work highlights
Instructed by ETHZ to provide a legal assessment as part of the Digital Health for the Benefit of the Entire Population project.
Practice head
Eva von Mühlenen
Other key lawyers
Tatjana Sachse